O	0	3	p53	p53	NN	B-NP
O	4	7	hot	hot	JJ	I-NP
O	7	8	-	-	HYPH	I-NP
O	8	12	spot	spot	NN	I-NP
O	13	20	mutants	mutant	NNS	I-NP
O	21	29	increase	increase	VBP	B-VP
B-Cancer	30	35	tumor	tumor	NN	B-NP
O	36	51	vascularization	vascularization	NN	I-NP
O	52	55	via	via	IN	B-PP
O	56	59	ROS	ROS	NN	B-NP
O	59	60	-	-	HYPH	O
O	60	68	mediated	mediate	VBN	B-NP
O	69	79	activation	activation	NN	I-NP
O	80	82	of	of	IN	B-PP
O	83	86	the	the	DT	B-NP
O	87	91	HIF1	HIF1	NN	I-NP
O	91	92	/	/	SYM	B-NP
O	92	96	VEGF	VEGF	NN	I-NP
O	96	97	-	-	HYPH	B-NP
O	97	98	A	A	NN	I-NP
O	99	106	pathway	pathway	NN	I-NP
O	106	107	.	.	.	O

O	108	111	The	The	DT	B-NP
O	112	120	function	function	NN	I-NP
O	121	123	of	of	IN	B-PP
O	124	127	p53	p53	NN	B-NP
B-Cancer	128	133	tumor	tumor	NN	I-NP
O	134	144	suppressor	suppressor	NN	I-NP
O	145	147	is	be	VBZ	B-VP
O	148	153	often	often	RB	I-VP
O	154	161	altered	alter	VBN	I-VP
O	162	164	in	in	IN	B-PP
O	165	172	various	various	JJ	B-NP
O	173	178	human	human	JJ	I-NP
B-Cancer	179	185	tumors	tumor	NNS	I-NP
O	186	199	predominantly	predominantly	RB	B-ADVP
O	200	207	through	through	IN	B-PP
O	208	216	missense	missense	JJ	B-NP
O	216	217	-	-	HYPH	I-NP
O	217	226	mutations	mutation	NNS	I-NP
O	227	236	resulting	result	VBG	B-VP
O	237	239	in	in	IN	B-PP
O	240	252	accumulation	accumulation	NN	B-NP
O	253	255	of	of	IN	B-PP
O	256	262	mutant	mutant	JJ	B-NP
O	263	271	proteins	protein	NNS	I-NP
O	271	272	.	.	.	O

O	273	275	We	We	PRP	B-NP
O	276	284	revealed	reveal	VBD	B-VP
O	285	289	that	that	IN	B-SBAR
O	290	300	expression	expression	NN	B-NP
O	301	303	of	of	IN	B-PP
O	304	307	p53	p53	NN	B-NP
O	308	316	proteins	protein	NNS	I-NP
O	317	321	with	with	IN	B-PP
O	322	327	amino	amino	JJ	B-NP
O	327	328	-	-	HYPH	I-NP
O	328	332	acid	acid	NN	I-NP
O	333	346	substitutions	substitution	NNS	I-NP
O	347	349	at	at	IN	B-PP
O	350	356	codons	codon	NNS	B-NP
O	357	360	175	175	CD	B-NP
O	361	362	(	(	(	O
O	362	367	R175H	R175H	NN	B-NP
O	367	368	)	)	)	O
O	368	369	,	,	,	O
O	370	373	248	248	CD	B-NP
O	374	375	(	(	(	O
O	375	380	R248W	R248W	NN	B-NP
O	380	381	)	)	)	O
O	381	382	,	,	,	O
O	383	386	and	and	CC	O
O	387	390	273	273	CD	B-NP
O	391	392	(	(	(	O
O	392	397	R273H	R273H	NN	B-NP
O	397	398	)	)	)	O
O	398	399	,	,	,	O
O	400	412	representing	represent	VBG	B-VP
O	413	416	the	the	DT	B-NP
O	417	420	hot	hot	JJ	I-NP
O	420	421	-	-	HYPH	I-NP
O	421	426	spots	spot	NNS	I-NP
O	427	429	of	of	IN	B-PP
O	430	439	mutations	mutation	NNS	B-NP
O	440	442	in	in	IN	B-PP
O	443	450	various	various	JJ	B-NP
O	451	456	human	human	JJ	I-NP
B-Cancer	457	463	tumors	tumor	NNS	I-NP
O	463	464	,	,	,	O
O	465	474	increased	increase	VBD	B-VP
O	475	478	the	the	DT	B-NP
O	479	485	number	number	NN	I-NP
O	486	488	of	of	IN	B-PP
B-Multi-tissue_structure	489	496	vessels	vessel	NNS	B-NP
O	497	499	in	in	IN	B-PP
B-Cancer	500	506	HCT116	HCT116	NN	B-NP
I-Cancer	507	512	human	human	JJ	I-NP
I-Cancer	513	518	colon	colon	NN	I-NP
I-Cancer	519	528	carcinoma	carcinoma	NN	I-NP
I-Cancer	529	539	xenografts	xenograft	NNS	I-NP
O	540	543	and	and	CC	O
O	543	544	,	,	,	O
O	545	547	as	as	IN	B-PP
O	548	549	a	a	DT	B-NP
O	550	556	result	result	NN	I-NP
O	556	557	,	,	,	O
O	558	569	accelerated	accelerate	VBD	B-VP
O	570	575	their	their	PRP$	B-NP
O	576	582	growth	growth	NN	I-NP
O	582	583	.	.	.	O

O	584	595	Stimulation	Stimulation	NN	B-NP
O	596	598	of	of	IN	B-PP
B-Cancer	599	604	tumor	tumor	NN	B-NP
O	605	617	angiogenesis	angiogenesis	NN	I-NP
O	618	621	was	be	VBD	B-VP
O	622	631	connected	connect	VBN	I-VP
O	632	636	with	with	IN	B-PP
O	637	642	about	about	RB	B-NP
O	643	644	2	2	CD	I-NP
O	644	645	-	-	HYPH	I-NP
O	645	649	fold	fold	JJ	I-NP
O	650	658	increase	increase	NN	I-NP
O	659	661	in	in	IN	B-PP
B-Immaterial_anatomical_entity	662	675	intracellular	intracellular	JJ	B-NP
O	676	681	level	level	NN	I-NP
O	682	684	of	of	IN	B-PP
O	685	693	reactive	reactive	JJ	B-NP
O	694	700	oxygen	oxygen	NN	I-NP
O	701	708	species	specie	NNS	I-NP
O	709	710	(	(	(	O
O	710	713	ROS	ROS	NNS	B-NP
O	713	714	)	)	)	O
O	714	715	.	.	.	O

O	716	727	Antioxidant	Antioxidant	JJ	B-NP
O	728	729	N	N	NN	I-NP
O	729	730	-	-	HYPH	B-NP
O	730	736	acetyl	acetyl	NN	I-NP
O	736	737	-	-	HYPH	B-NP
O	737	738	l	l	NN	I-NP
O	738	739	-	-	HYPH	O
O	739	748	aspartate	aspartate	NN	B-NP
O	749	750	(	(	(	O
O	750	753	NAC	NAC	NN	B-NP
O	753	754	)	)	)	O
O	755	764	decreased	decrease	VBD	B-VP
B-Multi-tissue_structure	765	772	vessels	vessel	NNS	B-NP
O	773	779	number	number	NN	I-NP
O	780	782	in	in	IN	B-PP
B-Cancer	783	789	tumors	tumor	NNS	B-NP
O	790	796	formed	form	VBN	B-VP
O	797	799	by	by	IN	B-PP
B-Cell	800	805	cells	cell	NNS	B-NP
O	806	810	with	with	IN	B-PP
O	811	822	inactivated	inactivate	VBN	B-NP
O	823	826	p53	p53	NN	I-NP
O	827	830	and	and	CC	O
O	831	840	inhibited	inhibit	VBD	B-VP
O	841	846	their	their	PRP$	B-NP
O	847	853	growth	growth	NN	I-NP
O	853	854	.	.	.	O

O	855	861	Effect	Effect	NN	B-NP
O	862	864	of	of	IN	B-PP
O	865	868	ROS	ROS	NN	B-NP
O	869	871	on	on	IN	B-PP
O	872	884	angiogenesis	angiogenesis	NN	B-NP
O	885	887	in	in	IN	B-PP
B-Cancer	888	894	tumors	tumor	NNS	B-NP
O	895	905	expressing	express	VBG	B-VP
O	906	909	hot	hot	JJ	B-NP
O	909	910	-	-	HYPH	I-NP
O	910	914	spot	spot	NN	I-NP
O	915	918	p53	p53	NN	I-NP
O	919	926	mutants	mutant	NNS	I-NP
O	927	930	was	be	VBD	B-VP
O	931	941	correlated	correlate	VBN	I-VP
O	942	946	with	with	IN	B-PP
O	947	952	their	their	PRP$	B-NP
O	953	960	ability	ability	NN	I-NP
O	961	963	to	to	TO	B-VP
O	964	972	increase	increase	VB	I-VP
O	973	974	a	a	DT	B-NP
O	975	982	content	content	NN	I-NP
O	983	985	of	of	IN	B-PP
O	986	990	HIF1	HIF1	NN	B-NP
O	991	1006	transcriptional	transcriptional	JJ	I-NP
O	1007	1013	factor	factor	NN	I-NP
O	1014	1025	responsible	responsible	JJ	B-ADJP
O	1026	1029	for	for	IN	B-PP
O	1030	1032	up	up	RB	B-ADVP
O	1032	1033	-	-	HYPH	O
O	1033	1043	regulation	regulation	NN	B-NP
O	1044	1046	of	of	IN	B-PP
O	1047	1051	VEGF	VEGF	NN	B-NP
O	1051	1052	-	-	HYPH	B-NP
O	1052	1053	A	A	NN	I-NP
O	1054	1059	mRNAs	mRNA	NNS	I-NP
O	1059	1060	.	.	.	O

